Lixte Biotechnology Holdings, Inc.
General ticker "LIXT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.6M (TTM average)
Lixte Biotechnology Holdings, Inc. follows the US Stock Market performance with the rate: 45.5%.
Estimated limits based on current volatility of 4.4%: low 3.94$, high 4.30$
Factors to consider:
- Total employees count: 4 (0.0%) as of 2023
- Top business risk factors: Product development risks, Clinical trial delays, Business interruptions, Security breaches, Economic downturns and volatility
- Current price 20.5% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.10$, 3.53$]
- 2025-12-31 to 2026-12-31 estimated range: [0.87$, 2.85$]
Financial Metrics affecting the LIXT estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -70.39 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 72.21 > 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term LIXT quotes
Long-term LIXT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $6.31MM | $5.09MM | $3.57MM |
| Operating Income | $-6.31MM | $-5.09MM | $-3.57MM |
| Non-Operating Income | $-0.00MM | $0.00MM | $-0.01MM |
| Interest Expense | $0.01MM | $0.02MM | $0.00MM |
| R&D Expense | $1.35MM | $0.90MM | $0.73MM |
| Income(Loss) | $-6.31MM | $-5.09MM | $-3.59MM |
| Profit(Loss)* | $-6.31MM | $-5.09MM | $-3.59MM |
| Stockholders Equity | $5.17MM | $3.99MM | $0.83MM |
| Assets | $5.56MM | $4.31MM | $1.15MM |
| Operating Cash Flow | $-4.61MM | $-4.29MM | $-3.16MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $5.14MM | $3.14MM | $0.00MM |
| Earnings Per Share** | $-3.99 | $-2.66 | $-1.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.